Skip to main content

Posts

Showing posts with the label Epirant

EPIRANT (Ranitidine): Historical Profile and Global Withdrawal Status

1. Disclaimer The information provided in this document is intended solely for educational and professional reference purposes and does not constitute medical advice, diagnosis, or treatment. Clinical decisions must be based on the approved prescribing information issued by relevant regulatory authorities and the professional judgment of qualified healthcare providers. We do not guarantee the accuracy, currency or completeness of information regarding medications or medical products, and official sources should be verified before making any decisions. By using this blog, you agree to assume personal responsibility for relying on the information provided. 2. Summary EPIRANT® is a historical brand name for ranitidine hydrochloride, a histamine H₂-receptor antagonist formerly used to suppress gastric acid secretion in acid-related gastrointestinal disorders. Ranitidine products were globally withdrawn or suspended between 2019 and 2020...